ArticleMedChemComm2018

Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1

Anna G Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.